Functional Analysis of Tcl1 Using Tcl1-Deficient Mouse Embryonic Stem Cells

被引:11
作者
Miyazaki, Tatsushi [1 ]
Miyazaki, Satsuki [1 ]
Ashida, Masafumi [1 ]
Tanaka, Tomofumi [1 ]
Tashiro, Fumi [1 ]
Miyazaki, Jun-ichi [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Div Stem Cell Regulat Res, Suita, Osaka, Japan
关键词
BETA-CATENIN; SELF-RENEWAL; ES CELLS; TRANSCRIPTIONAL ACTIVATION; T-CELL; EXPRESSION; PLURIPOTENCY; WNT; DIFFERENTIATION; GENE;
D O I
10.1371/journal.pone.0071645
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Tcl1 is highly expressed in embryonic stem (ES) cells, but its expression rapidly decreases following differentiation. To assess Tcl1's roles in ES cells, we generated Tcl1-deficient and -overexpressing mouse ES cell lines. We found that Tcl1 was neither essential nor sufficient for maintaining the undifferentiated state. Tcl1 is reported to activate Akt and to enhance cell proliferation. We found that Tcl1 expression levels correlated positively with the proliferation rate and negatively with the apoptosis of ES cells, but did not affect Akt phosphorylation. On the other hand, the phosphorylation level of beta-catenin decreased in response to Tcl1 overexpression. We measured the beta-catenin activity using the TOPflash reporter assay, and found that wild-type ES cells had low activity, which Tcl1 overexpression enhanced 1.8-fold. When the canonical Wnt signaling is activated by beta-catenin stabilization, it reportedly helps maintain ES cells in the undifferentiated state. We then performed DNA microarray analyses between the Tcl1-deficient and -expressing ES cells. The results revealed that Tcl1 expression downregulated a distinct group of genes, including Ndp52, whose expression is very high in blastocysts but reduced in the primitive ectoderm. Based on these results, we discuss the possible roles of Tcl1 in ES cells.
引用
收藏
页数:10
相关论文
共 50 条
[21]   TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia [J].
Bresin, A. ;
D'Abundo, L. ;
Narducci, M. G. ;
Fiorenza, M. T. ;
Croce, C. M. ;
Negrini, M. ;
Russo, G. .
CELL DEATH & DISEASE, 2016, 7 :e2071-e2071
[22]   Identification and Functional Evaluation of Alternative Splice Variants of Dax1 in Mouse Embryonic Stem Cells [J].
Wang, Jiaqi ;
Huang, Yi ;
Zhang, Chen ;
Ruan, Yan ;
Tian, Yanping ;
Wang, Fengsheng ;
Xu, Yixiao ;
Yu, Meng ;
Wang, Jiangjun ;
Cheng, Yuda ;
Liu, Lianlian ;
Yang, Ran ;
Wang, Jiali ;
Yang, Yi ;
Xiong, Jiaxiang ;
Hu, Yan ;
Jian, Rui ;
Ni, Bing ;
Wu, Wei ;
Zhang, Junlei .
STEM CELLS AND DEVELOPMENT, 2023, 32 (17-18) :554-564
[23]   MicroRNA-deficient mouse embryonic stem cells acquire a functional interferon response [J].
Witteveldt, Jeroen ;
Knol, Lisanne I. ;
Macias, Sara .
ELIFE, 2019, 8
[24]   The Long Journey of TCL1 Transgenic Mice: Lessons Learned in the Last 15 Years [J].
Pekarsky, Yuri ;
Drusco, Alessandra ;
Kumchala, Prasanthi ;
Croce, Carlo M. ;
Zanesi, Nicola .
GENE EXPRESSION, 2015, 16 (03) :129-135
[25]   IDO1-Targeted Therapy Does Not Control Disease Development in the Eμ-TCL1 Mouse Model of Chronic Lymphocytic Leukemia [J].
Ozturk, Selcen ;
Kalter, Verena ;
Roessner, Philipp M. ;
Sunbul, Murat ;
Seiffert, Martina .
CANCERS, 2021, 13 (08)
[26]   T-Cell Leukemia/Lymphoma 1 (TCL1): An Oncogene Regulating Multiple Signaling Pathways [J].
Paduano, Francesco ;
Gaudio, Eugenio ;
Mensah, Afua A. ;
Pinton, Sandra ;
Bertoni, Francesco ;
Trapasso, Francesco .
FRONTIERS IN ONCOLOGY, 2018, 8
[27]   TCL1: a shared tumor-associated antigen for immunotherapy against B-cell lymphomas [J].
Weng, Jinsheng ;
Rawal, Seema ;
Chu, Fuliang ;
Park, Hyun Jun ;
Sharma, Rakesh ;
Delgado, David A. ;
Fayad, Luis ;
Fanale, Michelle ;
Romaguera, Jorge ;
Luong, Amber ;
Kwak, Larry W. ;
Neelapu, Sattva S. .
BLOOD, 2012, 120 (08) :1613-1623
[28]   Evidence for Non-Cancer-Specific T Cell Exhaustion in the Tcl1 Mouse Model for Chronic Lymphocytic Leukemia [J].
Parigger, Thomas ;
Gassner, Franz Josef ;
Scherhaeufl, Christian ;
Abu Bakar, Aryunni ;
Hoepner, Jan Philip ;
Hoedlmoser, Alexandra ;
Steiner, Markus ;
Catakovic, Kemal ;
Geisberger, Roland ;
Greil, Richard ;
Zaborsky, Nadja .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (13)
[29]   Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL [J].
Schrader, A. ;
Crispatzu, G. ;
Oberbeck, S. ;
Mayer, P. ;
Putzer, S. ;
von Jan, J. ;
Vasyutina, E. ;
Warner, K. ;
Weit, N. ;
Pflug, N. ;
Braun, T. ;
Andersson, E. I. ;
Yadav, B. ;
Riabinska, A. ;
Maurer, B. ;
Ferreira, M. S. Ventura ;
Beier, F. ;
Altmueller, J. ;
Lanasa, M. ;
Herling, C. D. ;
Haferlach, T. ;
Stilgenbauer, S. ;
Hopfinger, G. ;
Peifer, M. ;
Bruemmendorf, T. H. ;
Nuernberg, P. ;
Elenitoba-Johnson, K. S. J. ;
Zha, S. ;
Hallek, M. ;
Moriggl, R. ;
Reinhardt, H. C. ;
Stern, M. -H. ;
Mustjoki, S. ;
Newrzela, S. ;
Frommolt, P. ;
Herling, M. .
NATURE COMMUNICATIONS, 2018, 9
[30]   Two types of BCR interactions are positively selected during leukemia development in the Eμ-TCL1 transgenic mouse model of CLL [J].
Iacovelli, Stefano ;
Hug, Eva ;
Bennardo, Sara ;
Duehren-von Minden, Marcus ;
Gobessi, Stefania ;
Rinaldi, Andrea ;
Suljagic, Mirza ;
Bilbao, Daniel ;
Bolasco, Giulia ;
Eckl-Dorna, Julia ;
Niederberger, Verena ;
Autore, Francesco ;
Sica, Simona ;
Laurenti, Luca ;
Wang, Hongsheng ;
Cornall, Richard J. ;
Clarke, Stephen H. ;
Croce, Carlo M. ;
Bertoni, Francesco ;
Jumaa, Hassan ;
Efremov, Dimitar G. .
BLOOD, 2015, 125 (10) :1578-1588